Literature DB >> 20506242

Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?

Lisa G Rider, Frederick W Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20506242      PMCID： PMC2946445          DOI： 10.1002/art.27525

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  29 in total

1.  Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

Authors:  Consuelo M López de Padilla; Abbe N Vallejo; Kelly T McNallan; Richard Vehe; Stephen A Smith; Allan B Dietz; Stanimir Vuk-Pavlovic; Ann M Reed
Journal:  Arthritis Rheum       Date:  2007-05

Review 2.  Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.

Authors:  Elizabeth M Dugan; Adam M Huber; Frederick W Miller; Lisa G Rider
Journal:  Dermatol Online J       Date:  2009-02-15

3.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

4.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

5.  Mast cells in neuromuscular diseases.

Authors:  T R Helliwell; O Gunhan; R H Edwards
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

6.  Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients.

Authors:  Angelo Ravelli; Lucia Trail; Cristina Ferrari; Nicolino Ruperto; Angela Pistorio; Clarissa Pilkington; Susan Maillard; Sheila K Oliveira; Flavio Sztajnbok; Ruben Cuttica; Matilde Beltramelli; Fabrizia Corona; Maria Martha Katsicas; Ricardo Russo; Virginia Ferriani; Ruben Burgos-Vargas; Silvia Magni-Manzoni; Eunice Solis-Valleoj; Marcia Bandeira; Francesco Zulian; Vicente Baca; Elisabetta Cortis; Fernanda Falcini; Maria Alessio; Maria Giannina Alpigiani; Valeria Gerloni; Claudia Saad-Magalhaes; Rosanna Podda; Clovis A Silva; Loredana Lepore; Enrico Felici; Federica Rossi; Elena Sala; Alberto Martini
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-01-15       Impact factor: 4.794

7.  The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Authors:  A M Huber; E M Dugan; P A Lachenbruch; B M Feldman; M D Perez; L S Zemel; C B Lindsley; R M Rennebohm; C A Wallace; M H Passo; A M Reed; S L Bowyer; S H Ballinger; F W Miller; L G Rider
Journal:  Rheumatology (Oxford)       Date:  2007-10       Impact factor: 7.580

8.  Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Authors:  David M Lee; Daniel S Friend; Michael F Gurish; Christophe Benoist; Diane Mathis; Michael B Brenner
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

9.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Authors:  Stéphanie Christen-Zaech; Roopa Seshadri; Joyce Sundberg; Amy S Paller; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2008-02

Review 10.  Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice.

Authors:  Fukumi Furukawa; Takashi Yoshimasu; Yuki Yamamoto; Nobuo Kanazawa; Takao Tachibana
Journal:  Autoimmun Rev       Date:  2009-01-20       Impact factor: 9.754
View more
  3 in total

Review 1.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  [New aspects on the pathogenesis of myositis].

Authors:  B Stuhlmüller; E Feist; T Häupl; G-R Burmester; N Pipitone
Journal:  Z Rheumatol       Date:  2013-04       Impact factor: 1.372

Review 3.  Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.

Authors:  William Coley; Sree Rayavarapu; Kanneboyina Nagaraju
Journal:  Arthritis Res Ther       Date:  2012-04-27       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.